| CCVAX | VSCIX | CCVAX / VSCIX | |
| Total Expense Ratio | 1.19 | 0.04 | 2,975% |
| Annual Report Gross Expense Ratio | 1.19 | 0.04 | 2,975% |
| Fund Existence | 21 years | 28 years | - |
| Gain YTD | -6.295 | 6.768 | -93% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.22B | 162B | 1% |
| Annual Yield % from dividends | 0.15 | 1.35 | 11% |
| Returns for 1 year | -12.29 | 1.45 | -846% |
| Returns for 3 years | 10.74 | 33.27 | 32% |
| Returns for 5 years | 16.36 | 48.42 | 34% |
| Returns for 10 years | 41.24 | 138.34 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LIAGX | 17.47 | 0.09 | +0.52% |
| Lord Abbett International Growth I | |||
| MAGCX | 32.40 | 0.10 | +0.31% |
| BlackRock Advantage Global Institutional | |||
| IVGIX | 19.60 | 0.06 | +0.31% |
| VY® Invesco Growth and Income I | |||
| FASDX | 18.39 | N/A | N/A |
| Fidelity Advisor Strategic Div & Inc A | |||
| IBLLX | 36.62 | N/A | N/A |
| Transamerica Multi-Managed Balanced C | |||